Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 39)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
9-Feb-10New Constructs, LLCN/ACL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (Global)144$169  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169  View Abstract
7-Feb-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: COLGATE-PALMOLIVE CO5$25  View Abstract
6-Feb-10Reuters Investment ProfileN/AOrissa Minerals Development Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
6-Feb-10Reuters Investment ProfileN/AWilliamson Tea Assam Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
6-Feb-10Reuters Investment ProfileN/AApeejay Tea Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
5-Feb-10Reuters Investment ProfileN/AColgate-Palmolive Co: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
Next 20
Brokerage Reports (Showing 1 to 3 of 3)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
1-Feb-10Caris & CompanyLinda Bolton WeiserCL - Raising Estimates, Price Target to $9611$25  View Abstract
28-Jan-10EnamJagdishwar ToppoNALCO - Results Update - 27 January 20103$10  View Abstract
12-Jan-10Caris & CompanyLinda Bolton WeiserCL-Company Provides Constructive Clarification9$25  View Abstract
Independent Reports (Showing 1 to 10 of 36)
Release
Date [down]		 Contributor Author Title Pages Price More Info
9-Feb-10New Constructs, LLCN/ACL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (Global)144$169View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169View Abstract
7-Feb-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: COLGATE-PALMOLIVE CO5$25View Abstract
6-Feb-10Reuters Investment ProfileN/AOrissa Minerals Development Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
6-Feb-10Reuters Investment ProfileN/AWilliamson Tea Assam Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
6-Feb-10Reuters Investment ProfileN/AApeejay Tea Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
5-Feb-10Reuters Investment ProfileN/AColgate-Palmolive Co: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.